AstraZeneca and its roxadustat partner FibroGen headed into a high-stakes FDA expert meeting this week after receiving tough safety questions about the med from agency staffers. The daylong event Thursday featured bruising feedback, and their application now faces even more uncertainty. In a 13 to 1 vote, FDA committee panelists said that the drug should not be approved… Read More »
A panel of independent experts advising the Centers for Disease Control and Prevention (CDC) plans to consider additional doses of COVID-19 vaccine in a small fraction of the population with weakened immune systems. The Advisory Committee on Immunization Practices (ACIP) plans to convene on July 22 to discuss “clinical considerations for additional doses in immunocompromised… Read More »
Overdose deaths hit a record 93,000 amid coronavirus last year due to pandemic-driven instabilities and loss of support systems, inaccess to medical care and the increasing presence of deadly synthetic opioids, top experts in addiction suspect. “It’s a horrifically tragic loss of life, particularly considering where we have been going as a country, as a… Read More »
When the shooting starts, the vendor makes himself scarce, leaving his melons on the table and hoping for the best. When it stops, selling resumes, to customers now all too rare. “I don’t have a choice. I’ve got to sell the melons,” said the vendor, Abdel Alim, speaking to New York Times journalists while he… Read More »